How to Develop a Competitive Generic Drug Portfolio

The volatile U.S. generic drug market is prompting proposals to optimize costs and availability. Proposals include restricting market entry to stabilize prices, long-term contracts between manufacturers and distributors to assure product demand, and creating a futures market for forecasting demand and risk management. Additionally, implementing strategic scaling, portfolio management, and FDA guidance could result in a more competitive market and ensure patients’ access to affordable medications.